Welcome to our dedicated page for Zepp Health Corporation SEC filings (Ticker: ZEPP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Zepp Health’s cross-border supply chain, proprietary AI chips, and dual revenue model make its SEC disclosures anything but light reading. Finding where management details Amazfit sales versus Xiaomi OEM volumes, or how new U.S. export controls might hit sensor sourcing, can take hours.
Stock Titan turns those 10-K and 10-Q marathons into five-minute briefs. Our AI-powered summaries spotlight exactly where Zepp Health records R&D outlays, data-privacy risk factors, and segment margins. Real-time alerts push every Zepp Health insider trading Form 4 transaction to your dashboard the moment it hits EDGAR, so you never miss executive stock transactions. Need the numbers fast? Open the latest Zepp Health quarterly earnings report 10-Q filing and skim AI-generated key metrics, or review a line-by-line Zepp Health earnings report filing analysis without downloading a single PDF.
The platform covers all disclosures—annual report 10-K simplified for non-accountants, 8-K material events explained when supply-chain news breaks, and the proxy statement executive compensation section mapped to performance targets. Use our search bar exactly as you’d ask an analyst: “understanding Zepp Health SEC documents with AI” or “Zepp Health Form 4 insider transactions real-time,” and get answers in seconds. Whether you’re tracking patent litigation updates, vendor concentration, or currency exposure, Stock Titan delivers comprehensive Zepp Health SEC filings explained simply so you can make informed decisions faster.
Zepp Health Corporation Form 144 reports a proposed sale of 44,000 Class A ordinary shares (American depositary shares representing underlying Class A shares) with an aggregate market value of $411,070.00. The shares represent a small portion of the company's outstanding stock of 114,776,364 shares and are planned to be sold on the NYSE with an approximate sale date of 09/04/2025. The filer acquired the securities on 02/12/2018 through stock options that vested on that date. The filing states there were no securities sold in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.
Zepp Health Corporation (ZEPP) filing a Form 144 notifies a proposed sale of 1,745 ADRs representing American depositary shares, with an aggregate market value of $60,656.20. The ADRs trade on the NYSE and the filing lists an approximate sale date of 08/27/2025. The securities were acquired through the vesting of restricted share units from Zepp Health between March 2018 and February 2020, and no sales by the holder in the past three months were reported.
Amendment No. 7 to Schedule 13G discloses that FIL Limited, Pandanus Partners, L.P. and Pandanus Associates, Inc. have completely exited their position in Zepp Health Corp (symbol ZEPP). As of the event date 31 Jul 2025, the group reports 0 Class A common shares (CUSIP CIB882000), equating to 0.0 % of the outstanding class. Consequently, the filers now fall below the 5 % reporting threshold. All voting and dispositive powers are reported as 0, and the certification confirms the securities were held in the ordinary course, not to influence control. The filing is signed 06 Aug 2025 by Richard Bourgelas under powers of attorney for each entity.
Allspring Global Investments Holdings, LLC has filed Amendment No. 7 to Schedule 13G declaring its current ownership in Zepp Health Corp (symbol ZEPP) as of 30 June 2025.
- Shares owned: 9,757,152 American Depositary Receipts (ADRs).
- Ownership percentage: 8.7 % of the outstanding ADR class, exceeding the 5 % reporting threshold.
- Voting/dispositive power: Sole voting power and sole dispositive power over the entire position; no shared power reported.
- Holder classification: Designated as a Holding Company/Control person (Item 3 — HC).
- Stake origin: Securities are held for clients of subsidiaries Allspring Global Investments, LLC and Allspring Funds Management, LLC; no single client holds more than 5 % of the class.
- Intent statement: Filing certifies the position was acquired in the ordinary course of business and not to influence control of Zepp Health.
- Signatories & dates: Event date 06-30-2025; filing signed by Senior Compliance Manager Jennifer Grunberg on 07-14-2025.
This disclosure signals a sizeable passive institutional position in Zepp Health, potentially viewed by the market as a vote of confidence in the company’s prospects without implying activist intentions.
FAQ
What is the current stock price of Zepp Health Corporation (ZEPP)?
What is the market cap of Zepp Health Corporation (ZEPP)?
